カテゴリ： 世界, 医療/バイオ, Market Monitor Global

脂質マイクロバブル造影剤のグローバル市場展望 2023年-2029年：ミクロン、ナノスケール

■ 英語タイトル：Lipid Microbubble Contrast Agent Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC13451）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC13451
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療機器＆消耗品
■ ページ数：78
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[脂質マイクロバブル造影剤のグローバル市場展望 2023年-2029年：ミクロン、ナノスケール]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の脂質マイクロバブル造影剤市場規模と予測を収録しています。・世界の脂質マイクロバブル造影剤市場：売上、2018年-2023年、2024年-2029年
・世界の脂質マイクロバブル造影剤市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の脂質マイクロバブル造影剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ミクロン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

脂質マイクロバブル造影剤のグローバル主要企業は、Lantheus Medical Imaging、 Bracco SpA、 GE Healthcare、 Daiichi Sankyo Company、 Bayer、 Guerbet Group、 Hengrui Medicine、 BeiLu Pharmaceutical、 Qihui Biologyなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、脂質マイクロバブル造影剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の脂質マイクロバブル造影剤市場：タイプ別、2018年-2023年、2024年-2029年
世界の脂質マイクロバブル造影剤市場：タイプ別市場シェア、2022年
・ミクロン、ナノスケール

世界の脂質マイクロバブル造影剤市場：用途別、2018年-2023年、2024年-2029年
世界の脂質マイクロバブル造影剤市場：用途別市場シェア、2022年
・病院、診療所、その他

世界の脂質マイクロバブル造影剤市場：地域・国別、2018年-2023年、2024年-2029年
世界の脂質マイクロバブル造影剤市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における脂質マイクロバブル造影剤のグローバル売上、2018年-2023年
・主要企業における脂質マイクロバブル造影剤のグローバル売上シェア、2022年
・主要企業における脂質マイクロバブル造影剤のグローバル販売量、2018年-2023年
・主要企業における脂質マイクロバブル造影剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Lantheus Medical Imaging、 Bracco SpA、 GE Healthcare、 Daiichi Sankyo Company、 Bayer、 Guerbet Group、 Hengrui Medicine、 BeiLu Pharmaceutical、 Qihui Biology

*************************************************************

・調査・分析レポートの概要
脂質マイクロバブル造影剤市場の定義
市場セグメント
世界の脂質マイクロバブル造影剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の脂質マイクロバブル造影剤市場規模
世界の脂質マイクロバブル造影剤市場規模：2022年 VS 2029年
世界の脂質マイクロバブル造影剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの脂質マイクロバブル造影剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の脂質マイクロバブル造影剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ミクロン、ナノスケール
脂質マイクロバブル造影剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
脂質マイクロバブル造影剤の用途別グローバル売上・予測

・地域別市場分析
地域別脂質マイクロバブル造影剤市場規模 2022年と2029年
地域別脂質マイクロバブル造影剤売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Lantheus Medical Imaging、 Bracco SpA、 GE Healthcare、 Daiichi Sankyo Company、 Bayer、 Guerbet Group、 Hengrui Medicine、 BeiLu Pharmaceutical、 Qihui Biology
...

This research report provides a comprehensive analysis of the Lipid Microbubble Contrast Agent market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Lipid Microbubble Contrast Agent market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Lipid Microbubble Contrast Agent, challenges faced by the industry, and potential opportunities for market players.
The global Lipid Microbubble Contrast Agent market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Lipid Microbubble Contrast Agent market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Lipid Microbubble Contrast Agent market. Additionally, the growing consumer demand present avenues for market expansion.
The global Lipid Microbubble Contrast Agent market was valued at US$ 532.9 million in 2022 and is projected to reach US$ 763.5 million by 2029, at a CAGR of 5.3% during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The research report on the Lipid Microbubble Contrast Agent market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Lipid Microbubble Contrast Agent market.
Market Overview: The report provides a comprehensive overview of the Lipid Microbubble Contrast Agent market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Micron, Nanoscale), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Lipid Microbubble Contrast Agent market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Lipid Microbubble Contrast Agent market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Lipid Microbubble Contrast Agent market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Lipid Microbubble Contrast Agent market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Lipid Microbubble Contrast Agent market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Lipid Microbubble Contrast Agent market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Lipid Microbubble Contrast Agent, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Lipid Microbubble Contrast Agent market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Lipid Microbubble Contrast Agent market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Micron
Nanoscale
Market segment by Application
Hospital
Clinic
Other
Global Lipid Microbubble Contrast Agent Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Lantheus Medical Imaging
Bracco SpA
GE Healthcare
Daiichi Sankyo Company
Bayer
Guerbet Group
Hengrui Medicine
BeiLu Pharmaceutical
Qihui Biology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Lipid Microbubble Contrast Agent, market overview.
Chapter 2: Global Lipid Microbubble Contrast Agent market size in revenue and volume.
Chapter 3: Detailed analysis of Lipid Microbubble Contrast Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lipid Microbubble Contrast Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Lipid Microbubble Contrast Agent capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Lipid Microbubble Contrast Agent Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lipid Microbubble Contrast Agent Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lipid Microbubble Contrast Agent Overall Market Size
2.1 Global Lipid Microbubble Contrast Agent Market Size: 2022 VS 2029
2.2 Global Lipid Microbubble Contrast Agent Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Lipid Microbubble Contrast Agent Sales: 2018-2029
3 Company Landscape
3.1 Top Lipid Microbubble Contrast Agent Players in Global Market
3.2 Top Global Lipid Microbubble Contrast Agent Companies Ranked by Revenue
3.3 Global Lipid Microbubble Contrast Agent Revenue by Companies
3.4 Global Lipid Microbubble Contrast Agent Sales by Companies
3.5 Global Lipid Microbubble Contrast Agent Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Lipid Microbubble Contrast Agent Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Lipid Microbubble Contrast Agent Product Type
3.8 Tier 1, Tier 2 and Tier 3 Lipid Microbubble Contrast Agent Players in Global Market
3.8.1 List of Global Tier 1 Lipid Microbubble Contrast Agent Companies
3.8.2 List of Global Tier 2 and Tier 3 Lipid Microbubble Contrast Agent Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Lipid Microbubble Contrast Agent Market Size Markets, 2022 & 2029
4.1.2 Micron
4.1.3 Nanoscale
4.2 By Type – Global Lipid Microbubble Contrast Agent Revenue & Forecasts
4.2.1 By Type – Global Lipid Microbubble Contrast Agent Revenue, 2018-2023
4.2.2 By Type – Global Lipid Microbubble Contrast Agent Revenue, 2024-2029
4.2.3 By Type – Global Lipid Microbubble Contrast Agent Revenue Market Share, 2018-2029
4.3 By Type – Global Lipid Microbubble Contrast Agent Sales & Forecasts
4.3.1 By Type – Global Lipid Microbubble Contrast Agent Sales, 2018-2023
4.3.2 By Type – Global Lipid Microbubble Contrast Agent Sales, 2024-2029
4.3.3 By Type – Global Lipid Microbubble Contrast Agent Sales Market Share, 2018-2029
4.4 By Type – Global Lipid Microbubble Contrast Agent Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Lipid Microbubble Contrast Agent Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Lipid Microbubble Contrast Agent Revenue & Forecasts
5.2.1 By Application – Global Lipid Microbubble Contrast Agent Revenue, 2018-2023
5.2.2 By Application – Global Lipid Microbubble Contrast Agent Revenue, 2024-2029
5.2.3 By Application – Global Lipid Microbubble Contrast Agent Revenue Market Share, 2018-2029
5.3 By Application – Global Lipid Microbubble Contrast Agent Sales & Forecasts
5.3.1 By Application – Global Lipid Microbubble Contrast Agent Sales, 2018-2023
5.3.2 By Application – Global Lipid Microbubble Contrast Agent Sales, 2024-2029
5.3.3 By Application – Global Lipid Microbubble Contrast Agent Sales Market Share, 2018-2029
5.4 By Application – Global Lipid Microbubble Contrast Agent Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Lipid Microbubble Contrast Agent Market Size, 2022 & 2029
6.2 By Region – Global Lipid Microbubble Contrast Agent Revenue & Forecasts
6.2.1 By Region – Global Lipid Microbubble Contrast Agent Revenue, 2018-2023
6.2.2 By Region – Global Lipid Microbubble Contrast Agent Revenue, 2024-2029
6.2.3 By Region – Global Lipid Microbubble Contrast Agent Revenue Market Share, 2018-2029
6.3 By Region – Global Lipid Microbubble Contrast Agent Sales & Forecasts
6.3.1 By Region – Global Lipid Microbubble Contrast Agent Sales, 2018-2023
6.3.2 By Region – Global Lipid Microbubble Contrast Agent Sales, 2024-2029
6.3.3 By Region – Global Lipid Microbubble Contrast Agent Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Lipid Microbubble Contrast Agent Revenue, 2018-2029
6.4.2 By Country – North America Lipid Microbubble Contrast Agent Sales, 2018-2029
6.4.3 US Lipid Microbubble Contrast Agent Market Size, 2018-2029
6.4.4 Canada Lipid Microbubble Contrast Agent Market Size, 2018-2029
6.4.5 Mexico Lipid Microbubble Contrast Agent Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Lipid Microbubble Contrast Agent Revenue, 2018-2029
6.5.2 By Country – Europe Lipid Microbubble Contrast Agent Sales, 2018-2029
6.5.3 Germany Lipid Microbubble Contrast Agent Market Size, 2018-2029
6.5.4 France Lipid Microbubble Contrast Agent Market Size, 2018-2029
6.5.5 U.K. Lipid Microbubble Contrast Agent Market Size, 2018-2029
6.5.6 Italy Lipid Microbubble Contrast Agent Market Size, 2018-2029
6.5.7 Russia Lipid Microbubble Contrast Agent Market Size, 2018-2029
6.5.8 Nordic Countries Lipid Microbubble Contrast Agent Market Size, 2018-2029
6.5.9 Benelux Lipid Microbubble Contrast Agent Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Lipid Microbubble Contrast Agent Revenue, 2018-2029
6.6.2 By Region – Asia Lipid Microbubble Contrast Agent Sales, 2018-2029
6.6.3 China Lipid Microbubble Contrast Agent Market Size, 2018-2029
6.6.4 Japan Lipid Microbubble Contrast Agent Market Size, 2018-2029
6.6.5 South Korea Lipid Microbubble Contrast Agent Market Size, 2018-2029
6.6.6 Southeast Asia Lipid Microbubble Contrast Agent Market Size, 2018-2029
6.6.7 India Lipid Microbubble Contrast Agent Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Lipid Microbubble Contrast Agent Revenue, 2018-2029
6.7.2 By Country – South America Lipid Microbubble Contrast Agent Sales, 2018-2029
6.7.3 Brazil Lipid Microbubble Contrast Agent Market Size, 2018-2029
6.7.4 Argentina Lipid Microbubble Contrast Agent Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Lipid Microbubble Contrast Agent Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Lipid Microbubble Contrast Agent Sales, 2018-2029
6.8.3 Turkey Lipid Microbubble Contrast Agent Market Size, 2018-2029
6.8.4 Israel Lipid Microbubble Contrast Agent Market Size, 2018-2029
6.8.5 Saudi Arabia Lipid Microbubble Contrast Agent Market Size, 2018-2029
6.8.6 UAE Lipid Microbubble Contrast Agent Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Lantheus Medical Imaging
7.1.1 Lantheus Medical Imaging Company Summary
7.1.2 Lantheus Medical Imaging Business Overview
7.1.3 Lantheus Medical Imaging Lipid Microbubble Contrast Agent Major Product Offerings
7.1.4 Lantheus Medical Imaging Lipid Microbubble Contrast Agent Sales and Revenue in Global (2018-2023)
7.1.5 Lantheus Medical Imaging Key News & Latest Developments
7.2 Bracco SpA
7.2.1 Bracco SpA Company Summary
7.2.2 Bracco SpA Business Overview
7.2.3 Bracco SpA Lipid Microbubble Contrast Agent Major Product Offerings
7.2.4 Bracco SpA Lipid Microbubble Contrast Agent Sales and Revenue in Global (2018-2023)
7.2.5 Bracco SpA Key News & Latest Developments
7.3 GE Healthcare
7.3.1 GE Healthcare Company Summary
7.3.2 GE Healthcare Business Overview
7.3.3 GE Healthcare Lipid Microbubble Contrast Agent Major Product Offerings
7.3.4 GE Healthcare Lipid Microbubble Contrast Agent Sales and Revenue in Global (2018-2023)
7.3.5 GE Healthcare Key News & Latest Developments
7.4 Daiichi Sankyo Company
7.4.1 Daiichi Sankyo Company Company Summary
7.4.2 Daiichi Sankyo Company Business Overview
7.4.3 Daiichi Sankyo Company Lipid Microbubble Contrast Agent Major Product Offerings
7.4.4 Daiichi Sankyo Company Lipid Microbubble Contrast Agent Sales and Revenue in Global (2018-2023)
7.4.5 Daiichi Sankyo Company Key News & Latest Developments
7.5 Bayer
7.5.1 Bayer Company Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Lipid Microbubble Contrast Agent Major Product Offerings
7.5.4 Bayer Lipid Microbubble Contrast Agent Sales and Revenue in Global (2018-2023)
7.5.5 Bayer Key News & Latest Developments
7.6 Guerbet Group
7.6.1 Guerbet Group Company Summary
7.6.2 Guerbet Group Business Overview
7.6.3 Guerbet Group Lipid Microbubble Contrast Agent Major Product Offerings
7.6.4 Guerbet Group Lipid Microbubble Contrast Agent Sales and Revenue in Global (2018-2023)
7.6.5 Guerbet Group Key News & Latest Developments
7.7 Hengrui Medicine
7.7.1 Hengrui Medicine Company Summary
7.7.2 Hengrui Medicine Business Overview
7.7.3 Hengrui Medicine Lipid Microbubble Contrast Agent Major Product Offerings
7.7.4 Hengrui Medicine Lipid Microbubble Contrast Agent Sales and Revenue in Global (2018-2023)
7.7.5 Hengrui Medicine Key News & Latest Developments
7.8 BeiLu Pharmaceutical
7.8.1 BeiLu Pharmaceutical Company Summary
7.8.2 BeiLu Pharmaceutical Business Overview
7.8.3 BeiLu Pharmaceutical Lipid Microbubble Contrast Agent Major Product Offerings
7.8.4 BeiLu Pharmaceutical Lipid Microbubble Contrast Agent Sales and Revenue in Global (2018-2023)
7.8.5 BeiLu Pharmaceutical Key News & Latest Developments
7.9 Qihui Biology
7.9.1 Qihui Biology Company Summary
7.9.2 Qihui Biology Business Overview
7.9.3 Qihui Biology Lipid Microbubble Contrast Agent Major Product Offerings
7.9.4 Qihui Biology Lipid Microbubble Contrast Agent Sales and Revenue in Global (2018-2023)
7.9.5 Qihui Biology Key News & Latest Developments
8 Global Lipid Microbubble Contrast Agent Production Capacity, Analysis
8.1 Global Lipid Microbubble Contrast Agent Production Capacity, 2018-2029
8.2 Lipid Microbubble Contrast Agent Production Capacity of Key Manufacturers in Global Market
8.3 Global Lipid Microbubble Contrast Agent Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Lipid Microbubble Contrast Agent Supply Chain Analysis
10.1 Lipid Microbubble Contrast Agent Industry Value Chain
10.2 Lipid Microbubble Contrast Agent Upstream Market
10.3 Lipid Microbubble Contrast Agent Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Lipid Microbubble Contrast Agent Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Lipid Microbubble Contrast Agent in Global Market
Table 2. Top Lipid Microbubble Contrast Agent Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Lipid Microbubble Contrast Agent Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Lipid Microbubble Contrast Agent Revenue Share by Companies, 2018-2023
Table 5. Global Lipid Microbubble Contrast Agent Sales by Companies, (K Units), 2018-2023
Table 6. Global Lipid Microbubble Contrast Agent Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Lipid Microbubble Contrast Agent Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Lipid Microbubble Contrast Agent Product Type
Table 9. List of Global Tier 1 Lipid Microbubble Contrast Agent Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lipid Microbubble Contrast Agent Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Lipid Microbubble Contrast Agent Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Lipid Microbubble Contrast Agent Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Lipid Microbubble Contrast Agent Sales (K Units), 2018-2023
Table 15. By Type - Global Lipid Microbubble Contrast Agent Sales (K Units), 2024-2029
Table 16. By Application – Global Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Lipid Microbubble Contrast Agent Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Lipid Microbubble Contrast Agent Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Lipid Microbubble Contrast Agent Sales (K Units), 2018-2023
Table 20. By Application - Global Lipid Microbubble Contrast Agent Sales (K Units), 2024-2029
Table 21. By Region – Global Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Lipid Microbubble Contrast Agent Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Lipid Microbubble Contrast Agent Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Lipid Microbubble Contrast Agent Sales (K Units), 2018-2023
Table 25. By Region - Global Lipid Microbubble Contrast Agent Sales (K Units), 2024-2029
Table 26. By Country - North America Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Lipid Microbubble Contrast Agent Sales, (K Units), 2018-2023
Table 29. By Country - North America Lipid Microbubble Contrast Agent Sales, (K Units), 2024-2029
Table 30. By Country - Europe Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Lipid Microbubble Contrast Agent Sales, (K Units), 2018-2023
Table 33. By Country - Europe Lipid Microbubble Contrast Agent Sales, (K Units), 2024-2029
Table 34. By Region - Asia Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Lipid Microbubble Contrast Agent Sales, (K Units), 2018-2023
Table 37. By Region - Asia Lipid Microbubble Contrast Agent Sales, (K Units), 2024-2029
Table 38. By Country - South America Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Lipid Microbubble Contrast Agent Sales, (K Units), 2018-2023
Table 41. By Country - South America Lipid Microbubble Contrast Agent Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Lipid Microbubble Contrast Agent Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Lipid Microbubble Contrast Agent Sales, (K Units), 2024-2029
Table 46. Lantheus Medical Imaging Company Summary
Table 47. Lantheus Medical Imaging Lipid Microbubble Contrast Agent Product Offerings
Table 48. Lantheus Medical Imaging Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Lantheus Medical Imaging Key News & Latest Developments
Table 50. Bracco SpA Company Summary
Table 51. Bracco SpA Lipid Microbubble Contrast Agent Product Offerings
Table 52. Bracco SpA Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Bracco SpA Key News & Latest Developments
Table 54. GE Healthcare Company Summary
Table 55. GE Healthcare Lipid Microbubble Contrast Agent Product Offerings
Table 56. GE Healthcare Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. GE Healthcare Key News & Latest Developments
Table 58. Daiichi Sankyo Company Company Summary
Table 59. Daiichi Sankyo Company Lipid Microbubble Contrast Agent Product Offerings
Table 60. Daiichi Sankyo Company Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Daiichi Sankyo Company Key News & Latest Developments
Table 62. Bayer Company Summary
Table 63. Bayer Lipid Microbubble Contrast Agent Product Offerings
Table 64. Bayer Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Bayer Key News & Latest Developments
Table 66. Guerbet Group Company Summary
Table 67. Guerbet Group Lipid Microbubble Contrast Agent Product Offerings
Table 68. Guerbet Group Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Guerbet Group Key News & Latest Developments
Table 70. Hengrui Medicine Company Summary
Table 71. Hengrui Medicine Lipid Microbubble Contrast Agent Product Offerings
Table 72. Hengrui Medicine Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Hengrui Medicine Key News & Latest Developments
Table 74. BeiLu Pharmaceutical Company Summary
Table 75. BeiLu Pharmaceutical Lipid Microbubble Contrast Agent Product Offerings
Table 76. BeiLu Pharmaceutical Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. BeiLu Pharmaceutical Key News & Latest Developments
Table 78. Qihui Biology Company Summary
Table 79. Qihui Biology Lipid Microbubble Contrast Agent Product Offerings
Table 80. Qihui Biology Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Qihui Biology Key News & Latest Developments
Table 82. Lipid Microbubble Contrast Agent Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 83. Global Lipid Microbubble Contrast Agent Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Lipid Microbubble Contrast Agent Production by Region, 2018-2023 (K Units)
Table 85. Global Lipid Microbubble Contrast Agent Production by Region, 2024-2029 (K Units)
Table 86. Lipid Microbubble Contrast Agent Market Opportunities & Trends in Global Market
Table 87. Lipid Microbubble Contrast Agent Market Drivers in Global Market
Table 88. Lipid Microbubble Contrast Agent Market Restraints in Global Market
Table 89. Lipid Microbubble Contrast Agent Raw Materials
Table 90. Lipid Microbubble Contrast Agent Raw Materials Suppliers in Global Market
Table 91. Typical Lipid Microbubble Contrast Agent Downstream
Table 92. Lipid Microbubble Contrast Agent Downstream Clients in Global Market
Table 93. Lipid Microbubble Contrast Agent Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Lipid Microbubble Contrast Agent Segment by Type in 2022
Figure 2. Lipid Microbubble Contrast Agent Segment by Application in 2022
Figure 3. Global Lipid Microbubble Contrast Agent Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Lipid Microbubble Contrast Agent Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Lipid Microbubble Contrast Agent Revenue, 2018-2029 (US$, Mn)
Figure 7. Lipid Microbubble Contrast Agent Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Lipid Microbubble Contrast Agent Revenue in 2022
Figure 9. By Type - Global Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Lipid Microbubble Contrast Agent Revenue Market Share, 2018-2029
Figure 11. By Type - Global Lipid Microbubble Contrast Agent Sales Market Share, 2018-2029
Figure 12. By Type - Global Lipid Microbubble Contrast Agent Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Lipid Microbubble Contrast Agent Revenue Market Share, 2018-2029
Figure 15. By Application - Global Lipid Microbubble Contrast Agent Sales Market Share, 2018-2029
Figure 16. By Application - Global Lipid Microbubble Contrast Agent Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Lipid Microbubble Contrast Agent Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Lipid Microbubble Contrast Agent Revenue Market Share, 2018-2029
Figure 20. By Region - Global Lipid Microbubble Contrast Agent Sales Market Share, 2018-2029
Figure 21. By Country - North America Lipid Microbubble Contrast Agent Revenue Market Share, 2018-2029
Figure 22. By Country - North America Lipid Microbubble Contrast Agent Sales Market Share, 2018-2029
Figure 23. US Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Lipid Microbubble Contrast Agent Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Lipid Microbubble Contrast Agent Sales Market Share, 2018-2029
Figure 28. Germany Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2018-2029
Figure 29. France Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Lipid Microbubble Contrast Agent Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Lipid Microbubble Contrast Agent Sales Market Share, 2018-2029
Figure 37. China Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2018-2029
Figure 41. India Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Lipid Microbubble Contrast Agent Revenue Market Share, 2018-2029
Figure 43. By Country - South America Lipid Microbubble Contrast Agent Sales Market Share, 2018-2029
Figure 44. Brazil Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Lipid Microbubble Contrast Agent Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Lipid Microbubble Contrast Agent Sales Market Share, 2018-2029
Figure 48. Turkey Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Lipid Microbubble Contrast Agent Revenue, (US$, Mn), 2018-2029
Figure 52. Global Lipid Microbubble Contrast Agent Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Lipid Microbubble Contrast Agent by Region, 2022 VS 2029
Figure 54. Lipid Microbubble Contrast Agent Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の銅＆銅合金ホイル（<100 ミクロン）市場2022年：市場規模予測（～2028年）
  • 微小球超音波用凍結乾燥造影剤のグローバル市場展望 2023年-2029年：人間用、動物用
  • コレステロール脂質濃縮物（250x）のグローバル市場展望 2023年-2029年：天然コレステロール脂質濃縮物、合成コレステロール脂質濃縮物
  • 脂質代謝異常症治療薬のグローバル市場展望 2023年-2029年：OTC、Rx治療薬
  • 脂質代謝疾患治療薬のグローバル市場展望 2023年-2029年：OTC、Rx治療薬
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC13451 )"脂質マイクロバブル造影剤のグローバル市場展望 2023年-2029年：ミクロン、ナノスケール" (英文：Lipid Microbubble Contrast Agent Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。